Compugen Ltd.
2.05
0.05 (2.50%)
At close: Jan 15, 2025, 10:16 AM

Compugen Ltd. Statistics

Share Statistics

Compugen Ltd. has 89.54M shares outstanding. The number of shares has increased by 0.01% in one year.

Shares Outstanding 89.54M
Shares Change (YoY) n/a
Shares Change (QoQ) 0%
Owned by Institutions (%) n/a
Shares Floating 84.72M
Failed to Deliver (FTD) Shares 418
FTD / Avg. Volume 0.1%

Short Selling Information

The latest short interest is 1.27M, so 1.42% of the outstanding shares have been sold short.

Short Interest 1.27M
Short % of Shares Out 1.42%
Short % of Float 1.5%
Short Ratio (days to cover) 6.42

Valuation Ratios

The PE ratio is -9.35 and the forward PE ratio is -14.55.

PE Ratio -9.35
Forward PE -14.55
PS Ratio 5.24
Forward PS 4
PB Ratio 2.67
P/FCF Ratio -4.86
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Compugen Ltd. has an Enterprise Value (EV) of 162.36M.

EV / Earnings -8.66
EV / Sales 4.85
EV / EBITDA -12.97
EV / EBIT -12.5
EV / FCF -4.5

Financial Position

The company has a current ratio of 4.36, with a Debt / Equity ratio of 0.02.

Current Ratio 4.36
Quick Ratio 4.36
Debt / Equity 0.02
Total Debt / Capitalization 2.02
Cash Flow / Debt -26.56
Interest Coverage -419.1

Financial Efficiency

Return on equity (ROE) is -0.29% and return on capital (ROIC) is -37.22%.

Return on Equity (ROE) -0.29%
Return on Assets (ROA) -0.15%
Return on Capital (ROIC) -37.22%
Revenue Per Employee 492.04K
Profits Per Employee -275.79K
Employee Count 68
Asset Turnover 0.28
Inventory Turnover 0

Taxes

Income Tax 8.97M
Effective Tax Rate -0.92

Stock Price Statistics

The stock price has increased by 3.65% in the last 52 weeks. The beta is 2.65, so Compugen Ltd.'s price volatility has been higher than the market average.

Beta 2.65
52-Week Price Change 3.65%
50-Day Moving Average 1.59
200-Day Moving Average 1.84
Relative Strength Index (RSI) 74.66
Average Volume (20 Days) 437.80K

Income Statement

In the last 12 months, Compugen Ltd. had revenue of 33.46M and earned -18.75M in profits. Earnings per share was -0.21.

Revenue 33.46M
Gross Profit 31.45M
Operating Income -12.99M
Net Income -18.75M
EBITDA -12.52M
EBIT -12.99M
Earnings Per Share (EPS) -0.21
Full Income Statement

Balance Sheet

The company has 13.89M in cash and 1.35M in debt, giving a net cash position of 12.54M.

Cash & Cash Equivalents 13.89M
Total Debt 1.35M
Net Cash 12.54M
Retained Earnings -474.53M
Total Assets 123.52M
Working Capital 87.07M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -35.89M and capital expenditures -172.00K, giving a free cash flow of -36.06M.

Operating Cash Flow -35.89M
Capital Expenditures -172.00K
Free Cash Flow -36.06M
FCF Per Share -0.41
Full Cash Flow Statement

Margins

Gross margin is 94.01%, with operating and profit margins of -38.83% and -56.05%.

Gross Margin 94.01%
Operating Margin -38.83%
Pretax Margin -29.24%
Profit Margin -56.05%
EBITDA Margin -37.41%
EBIT Margin -38.83%
FCF Margin -107.77%

Dividends & Yields

CGEN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -10.55%
FCF Yield -20.24%
Dividend Details

Analyst Forecast

The average price target for CGEN is $4, which is 101% higher than the current price. The consensus rating is "Buy".

Price Target $4
Price Target Difference 101%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score 2.97
Piotroski F-Score 4